The technology optimizes the microstructure of biomaterials to enable greater strength gain in resorbable implantables. It offers a platform upon which to develop next generation resorbable orthopedic products.
Proxy Biomedical is a company that focuses on biomaterial solutions for medical implantable products.
More articles on devices:
Smith & Nephew shares lost 7.14% last week — 5 key updates
Stryker shares drop 4.94% in 7 days: 5 things to know
Minimus Spine receives U.S. patent — 5 things to know
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
